ANDREW RACKHAM: Open Payments
NPI 1831556190 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,401 in 193 payments from 22 companies in 2025. Trend: 2023 $6,174 · 2024 $7,461 · 2025 $7,401
Food & beverage: $5,454Consulting: $1,760Education: $187
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 24 | $1,563 |
| Incyte Corporation | 4 | $1,162 |
| ABBVIE INC. | 27 | $976 |
| Galderma Laboratories, L.P. | 26 | $794 |
| GENZYME CORPORATION | 9 | $477 |
| LEO Pharma Inc. | 11 | $362 |
| Regeneron Healthcare Solutions, Inc. | 10 | $324 |
| Janssen Biotech, Inc. | 11 | $294 |
| Lilly USA, LLC | 4 | $279 |
| Novartis Pharmaceuticals Corporation | 8 | $249 |
Products named: Bimzelx, SKYRIZI, NEMLUVIO, DUPIXENT, RINVOQ, TREMFYA, AKLIEF, ANZUPGO.
Industry payments across NV — which companies pay providers there.
